Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - qingping+dou
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Identification of Galeterone's mechanism of action leading to novel treatment therapies for castrate resistant prostate cancer (CRPC)
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (HRPC), is a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT). The need for effective therapies for these difficult to treat cancers is gaining prominence in the prostate cancer market. The global CRPC market is poised...
Published: 4/16/2025
|
Inventor(s):
Qingping Dou
,
Huanjie Yang
,
Elisabeth Heath
Keywords(s):
Category(s):
Life Science
,
Oncology
,
Pharmaceuticals
,
Receptors/targets
,
Process/Procedure
,
Small molecule
,
Therapeutics